首頁 > 市場調查報告書 > 醫療設備

生技設備

生物晶片市場規模、佔有率和成長分析（按類型、製造技術、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902279

生物晶片市場規模、佔有率和成長分析（按類型、製造技術、應用、最終用戶和地區分類）－2026-2033年產業預測

Biochip Market Size, Share, and Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，生物晶片市場規模將達到 121 億美元，到 2025 年將達到 136.3 億美元，到 2033 年將達到 354.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.68%。

生物晶片市場正經歷顯著成長，這主要得益於對先進診斷解決方案和就地檢驗需求的不斷成長。慢性病發病率的上升以及蛋白質組學和基因組學在癌症研究中的應用進一步推動了這一成長。主要企業正致力於開發創新診斷測試，以因應慢性病（尤其是老年族群）日益成長的趨勢。由於實驗室晶片系統能夠有效診斷慢性病，因此其需求不斷成長。生物晶片因其樣本消費量低、能夠高效進行全蛋白質組分析（這對生物標記和藥物發現至關重要）而在生物醫學和舉措領域日益受到關注。此外，新產品的不斷湧入也顯著促進了市場的擴張。

生物晶片市場促進因素

基因組學和蛋白質組學的最新進展顯著影響著生物晶片市場，這些進展使我們對個體基因譜和疾病的潛在機制有了更深入的了解。這些知識的累積催生了對精準個人化醫療的需求。生物晶片是該領域不可或缺的工具，因為它們能夠快速有效地分析大量資料集，並有助於識別與各種健康狀況相關的特定基因突變和生物標記。向個人化醫療的轉變正在改善患者的治療效果，從而加速了生物晶片在臨床環境中的整合和應用，進而推動了市場成長。

生物晶片市場的限制因素

生物晶片市場面臨許多限制因素，主要在於開發先進生物晶片以確保其準確性和可靠性需要耗費大量成本和漫長的研發過程。將這些生物晶片整合到現有的醫療保健系統和檢查室基礎設施中需要大量的資金投入，這阻礙了許多醫療機構的廣泛採用。此外，持續的維護成本也增加了複雜性。儘管存在這些挑戰，但隨著時間的推移，技術進步和規模經濟的不斷擴大有望減輕這些經濟負擔，從而促進生物晶片在各種醫療保健環境中的普及和應用。

生物晶片市場趨勢

隨著相關人員日益重視根據個人基因譜量身定做的治療方案，生物晶片市場正呈現出向個人化醫療和精準診斷方向發展的顯著趨勢。基因組學和蛋白質組學的持續進步推動了這一需求，而生物晶片憑藉其處理海量基因數據和揭示蛋白質相互作用的能力，正處於這一領域的前沿。生物晶片與人工智慧和機器學習等先進技術的融合，不僅增強了其診斷能力，還催生了用於精準疾病識別和治療的創新工具。這種融合不僅提高了基因突變和生物標記檢測的準確性，也加速了個人化醫療解決方案的演進。

DNA晶片
- 基因表現
- SNP基因基因型鑒定
- 癌症診斷和治療
- 基因組學
- 藥物發現
- 農業生物技術
- 其他DNA晶片應用
晶片實驗室
- 臨床診斷
- 基因組學
- 體外診斷和即時檢測
- 蛋白質體學
- 藥物發現
- 其他 LoAC 應用
蛋白質晶片
- 蛋白質體學
- 表達譜分析
- 診斷
- 高通量篩檢
- 藥物發現
- 其他蛋白質晶片應用
其他數組
- 細胞陣列
- 組織陣列

生物晶片市場，依製造技術分類

微陣列
微流體技術

生物晶片市場，依應用領域分類

基因組學
藥物研發
農業
其他

生物晶片市場，依最終用戶分類

生物技術和製藥公司
醫院和診斷中心
學術和研究機構
其他最終用戶

生物晶片市場規模：（按地區分類）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Abbott Laboratories
Agilent Technologies, Inc.
PerkinElmer, Inc.
Standard BioTools Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Micronit Microtechnologies
Randox Laboratories Ltd.
RayBiotech, Inc.
Invitae
CapitalBio Corporation
Genscript Biotech Corp
Takara Bio Usa Holdings, Inc.

簡介目錄

Product Code: SQMIG45A2235

Biochip Market size was valued at USD 12.1 Billion in 2024 and is poised to grow from USD 13.63 Billion in 2025 to USD 35.43 Billion by 2033, growing at a CAGR of 12.68% during the forecast period (2026-2033).

The biochip market is witnessing substantial growth driven by increased demand for advanced diagnostic solutions and point-of-care testing. The rise of chronic diseases and the application of proteomics and genomics in cancer research further fuel this growth. Major players are focusing on developing innovative diagnostic tests, aligning with the growing prevalence of chronic conditions, particularly among the elderly. The demand for lab-on-a-chip systems is expanding as they facilitate effective diagnosis of chronic illnesses. Biochips are gaining traction in biomedical and biotechnological fields due to their low sample consumption and efficiency in proteome-wide analyses, which are vital for biomarker and drug discovery initiatives. Additionally, the introduction of novel products in the market has significantly impacted its expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biochip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biochip Market Segments Analysis

Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biochip Market

The biochip market is significantly influenced by recent advancements in genomics and proteomics, which enhance our understanding of individual genetic profiles and the underlying mechanisms of diseases. This growing knowledge creates a demand for precise and personalized medical treatments. Biochips are essential tools in this landscape, as they enable rapid and efficient analysis of extensive datasets, helping to identify specific genetic mutations and biomarkers linked to various health conditions. The shift towards personalized medicine is improving patient outcomes, subsequently accelerating the integration and use of biochips in clinical environments, thereby driving market growth.

Restraints in the Biochip Market

The biochip market faces several restraints primarily due to the substantial costs and lengthy processes associated with developing advanced biochips that guarantee accuracy and reliability. Integrating these biochips into current healthcare systems and laboratory infrastructures demands significant financial investments, which can be a hurdle for many healthcare facilities, hampering widespread adoption. Moreover, the ongoing maintenance costs add another layer of complexity. Despite these challenges, advancements in technology and increased economies of scale are anticipated to ease these financial burdens over time, potentially fostering greater acceptance and integration of biochips in various healthcare contexts.

Market Trends of the Biochip Market

The biochip market is experiencing a notable trend towards personalized medicine and precision diagnostics, as stakeholders increasingly prioritize treatments tailored to individual genetic profiles. The continued advancements in genomics and proteomics are fueling this demand, with biochips at the forefront due to their capacity to process extensive genetic data and elucidate protein interactions. The convergence of biochips with advanced technologies like artificial intelligence and machine learning enhances their diagnostic capabilities, leading to the development of innovative tools for precise disease identification and treatment. This alignment not only improves accuracy in detecting genetic mutations and biomarkers but also accelerates the evolution of personalized healthcare solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis

Biochips Market, By Type

Market Overview
DNA Chips
- Gene Expression
- SNP Genotyping
- Cancer Diagnosis & Treatment
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Other DNA Chip Applications
Lab-On-A-Chip
- Clinical Diagnostics
- Genomics
- IVD & POC
- Proteomics
- Drug Discovery
- Other Loac Applications
Protein Chips
- Proteomics
- Expression Profiling
- Diagnostics
- High-Throughput Screening
- Drug Discovery
- Other Protein Chip Applications
Other Arrays
- Cell Arrays
- Tissue Arrays

Biochips Market, By Fabrication Technology

Market Overview
Microarrays
Microfluidics

Biochips Market, By Application

Market Overview
Genomics
Drug Development
Agriculture
Others

Biochips Market, By End User

Market Overview
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users

Biochips Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microtechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Usa Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments